(VIANEWS) – Pioneer High Income Trust (PHT), PCM Fund (PCM), GlaxoSmithKline (GSK) are the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 Pioneer High Income Trust (PHT) 10.22 -0.58% 8.38% 2021-11-23 14:48:14
2 PCM Fund (PCM) 11.42 -0.02% 8% 2021-11-23 14:07:20
3 GlaxoSmithKline (GSK) 41.12 0% 5.41% 2021-11-30 17:15:41
4 Dreyfus Municipal Bond Infrastructure Fund (DMB) 14.19 -0.35% 4.48% 2021-11-29 08:12:06
5 PetMed Express (PETS) 28.45 0.64% 4.22% 2021-11-25 20:09:06
6 UNIVERSAL INSURANCE HOLDINGS (UVE) 15.61 0.71% 4.13% 2021-11-24 01:10:07
7 Hanesbrands (HBI) 16.41 -2.44% 3.57% 2021-11-29 17:10:07
8 Regency Centers Corporation (REG) 71.26 -4.16% 3.51% 2021-11-28 07:13:07
9 Johnson & Johnson (JNJ) 155.93 0% 2.56% 2021-11-30 16:48:37
10 Diamond Hill Investment Group (DHIL) 220.35 0.16% 2.22% 2021-11-24 19:44:13

Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Pioneer High Income Trust (PHT) – Dividend Yield: 8.38%

Pioneer High Income Trust is a closed ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc. It invests in fixed income markets of the United States. The fund primarily invests in below-investment-grade bonds, high-yield corporate bonds, and convertible securities. It seeks to invest in bonds that are rated BBB- or lower by Standard and Poor's or a similar national rating service. The fund benchmarks the performance of its portfolio against the Bank of America Merrill Lynch High Yield Master II Index. Pioneer High Income Trust was formed on April 25, 2002 and is domiciled in the United States.

Volume

Today’s last reported volume for Pioneer High Income Trust is 69861, 23.31% below its average volume of 91096.

Pioneer High Income Trust’s last close was $10.07, 10.25% under its 52-week high of $11.22.

Pioneer High Income Trust’s Revenue

Year-on-year quarterly revenue growth declined by 4.8%, now sitting on 27.55M for the twelve trailing months.

Pioneer High Income Trust’s Stock Yearly Top and Bottom Value

Pioneer High Income Trust’s stock is valued at $10.22 at 19:15 EST, below its 52-week high of $11.22 and way higher than its 52-week low of $8.54.

Pioneer High Income Trust’s Moving Average

Pioneer High Income Trust’s value is higher than its 50-day moving average of $10.15 and higher than its 200-day moving average of $9.92.

More news about Pioneer High Income Trust.

2. PCM Fund (PCM) – Dividend Yield: 8%

PCM Fund Inc. is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Company LLC. It seeks to invest in fixed income markets. The fund invests primarily in commercial mortgage-backed securities. It employs fundamental analysis with a focus on top down stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against Barclay's CMBS Investment Grade Index. PCM Fund Inc was formed on September 2, 1993 and is domiciled in the United States.

Volume

Today’s last reported volume for PCM Fund is 6950, 71.06% below its average volume of 24017.

PCM Fund’s last close was $11.21, 12.22% below its 52-week high of $12.77.

PCM Fund’s Revenue

Year-on-year quarterly revenue growth grew by 6.3%, now sitting on 14.13M for the twelve trailing months.

PCM Fund’s Stock Yearly Top and Bottom Value

PCM Fund’s stock is valued at $11.42 at 19:15 EST, way under its 52-week high of $12.77 and way higher than its 52-week low of $10.18.

PCM Fund’s Moving Average

PCM Fund’s worth is higher than its 50-day moving average of $11.32 and under its 200-day moving average of $11.55.

More news about PCM Fund.

3. GlaxoSmithKline (GSK) – Dividend Yield: 5.41%

GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Volume

Today’s last reported volume for GlaxoSmithKline is 3960370, 5.93% below its average volume of 4210220.

GlaxoSmithKline’s last close was $41.36, 5.16% under its 52-week high of $43.61.

GlaxoSmithKline’s Sales

GlaxoSmithKline’s sales growth is 7.9% for the current quarter and 6.6% for the next. The company’s growth estimates for the present quarter and the next is a negative 14% and a negative 1.6%, respectively.

GlaxoSmithKline’s Revenue

Year-on-year quarterly revenue growth declined by 18.4%, now sitting on 32.43B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

GlaxoSmithKline’s stock is considered to be overbought (>=80).

GlaxoSmithKline’s Stock Yearly Top and Bottom Value

GlaxoSmithKline’s stock is valued at $41.12 at 19:15 EST, below its 52-week high of $43.61 and way above its 52-week low of $33.53.

GlaxoSmithKline’s Moving Average

GlaxoSmithKline’s worth is higher than its 50-day moving average of $39.98 and above its 200-day moving average of $39.80.

More news about GlaxoSmithKline.

4. Dreyfus Municipal Bond Infrastructure Fund (DMB) – Dividend Yield: 4.48%

BNY Mellon Municipal Bond Infrastructure Fund, Inc. is a closed ended fixed income mutual fund launched and managed by BNY Mellon Investment Adviser, Inc. The fund invests in the fixed income markets of the United States. It primarily invests in the tax-exempt investment grade debt obligations issued by or on behalf of states, territories and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, or multistate agencies or authorities, and certain other specified securities. The fund invests its bonds issued by infrastructure sector including transportation, energy and utilities, social infrastructure, water and environment, and other similar public sectors which are rated as BBB- and above by S&P and Fitch and Baa3 and above by Moody's with an effective duration of up to 14 years. It employs fundamental and quantitative analysis with a bottom-up security picking approach by focusing on factors such as the relative value and attractiveness of various sectors and securities to seek to exploit pricing inefficiencies in the municipal bond market, actively trading among various sectors based on their apparent values, general economic and monetary conditions, prevailing interest rates and the condition of the general money market and the municipal bond market, the size of a particular offering, the maturity of the obligation, and the rating of the issue to create its portfolio. The fund was formerly known as Dreyfus Municipal Bond Infrastructure Fund, Inc. BNY Mellon Municipal Bond Infrastructure Fund, Inc. was formed on April 25, 2013 and is domiciled in the United States.

Volume

Today’s last reported volume for Dreyfus Municipal Bond Infrastructure Fund is 16396, 58.8% below its average volume of 39792.

Dreyfus Municipal Bond Infrastructure Fund’s last close was $14.47, 15.23% under its 52-week high of $17.07.

Dreyfus Municipal Bond Infrastructure Fund’s Revenue

Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 17.02M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Dreyfus Municipal Bond Infrastructure Fund’s stock is considered to be overbought (>=80).

Dreyfus Municipal Bond Infrastructure Fund’s Stock Yearly Top and Bottom Value

Dreyfus Municipal Bond Infrastructure Fund’s stock is valued at $14.19 at 19:15 EST, way under its 52-week high of $17.07 and higher than its 52-week low of $13.64.

Dreyfus Municipal Bond Infrastructure Fund’s Moving Average

Dreyfus Municipal Bond Infrastructure Fund’s worth is under its 50-day moving average of $15.30 and below its 200-day moving average of $14.92.

More news about Dreyfus Municipal Bond Infrastructure Fund.

5. PetMed Express (PETS) – Dividend Yield: 4.22%

PetMed Express, Inc., together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Volume

Today’s last reported volume for PetMed Express is 210032, 39.94% below its average volume of 349706.

PetMed Express’s last close was $29.49, 48.26% below its 52-week high of $57.00.

PetMed Express’s Revenue

Year-on-year quarterly revenue growth declined by 10.7%, now sitting on 284.27M for the twelve trailing months.

PetMed Express’s Stock Yearly Top and Bottom Value

PetMed Express’s stock is valued at $28.45 at 19:15 EST, way under its 52-week high of $57.00 and way above its 52-week low of $24.75.

PetMed Express’s Moving Average

PetMed Express’s worth is above its 50-day moving average of $28.13 and below its 200-day moving average of $30.64.

More news about PetMed Express.

6. UNIVERSAL INSURANCE HOLDINGS (UVE) – Dividend Yield: 4.13%

Universal Insurance Holdings, Inc., together with its subsidiaries, operates as an integrated insurance holding company in the United States. The company develops, markets, and underwrites insurance products for personal residential insurance, such as homeowners, renters/tenants, condo unit owners, and dwelling/fire; allied lines, coverage for other structures, and personal property; and commercial residential multi-peril, as well as liability and personal articles coverages. The company also advises on actuarial issues, oversees distribution, administers claims payments, performs policy administration and underwriting, and assists with reinsurance negotiations; places and manages reinsurance programs for the insurance entities; and operates Clovered, in which consumers receive side-by-side quotes from multiple carriers across multiple states, as well as educational materials about homeowners insurance policies. It offers its products through a network of independent agents, as well as Universal Direct, a direct-to-consumer online platform, which enables homeowners to directly purchase, pay for, and bind homeowners' policies. The company was formerly known as Universal Heights, Inc. and changed its name to Universal Insurance Holdings, Inc. in January 2001. Universal Insurance Holdings, Inc. was incorporated in 1990 and is headquartered in Fort Lauderdale, Florida.

Volume

Today’s last reported volume for UNIVERSAL INSURANCE HOLDINGS is 107712, 16.48% below its average volume of 128960.

UNIVERSAL INSURANCE HOLDINGS’s last close was $15.61, 5.79% under its 52-week high of $16.57.

UNIVERSAL INSURANCE HOLDINGS’s Sales

UNIVERSAL INSURANCE HOLDINGS’s sales growth is 18.4% for the current quarter and 20.4% for the next. The company’s growth estimates for the present quarter is 139.3% and a drop 13.1% for the next.

UNIVERSAL INSURANCE HOLDINGS’s Revenue

Year-on-year quarterly revenue growth declined by 7.8%, now sitting on 1.1B for the twelve trailing months.

UNIVERSAL INSURANCE HOLDINGS’s Stock Yearly Top and Bottom Value

UNIVERSAL INSURANCE HOLDINGS’s stock is valued at $15.61 at 19:15 EST, below its 52-week high of $16.57 and way above its 52-week low of $12.62.

UNIVERSAL INSURANCE HOLDINGS’s Moving Average

UNIVERSAL INSURANCE HOLDINGS’s worth is way above its 50-day moving average of $13.97 and way higher than its 200-day moving average of $14.12.

More news about UNIVERSAL INSURANCE HOLDINGS.

7. Hanesbrands (HBI) – Dividend Yield: 3.57%

Hanesbrands Inc., a consumer goods company, designs, manufactures, sources, and sells a range of basic apparel for men, women, and children in the United States. The company operates through three segments: Innerwear, Activewear, and International. It sells men's underwear, women's panties, children's underwear, activewear, socks, and hosiery, as well as intimate apparel, such as bras and shapewears; home goods; and T-shirts, fleece, sport shirts, performance T-shirts and shorts, sports bras, and thermals, as well as licensed logo apparel in collegiate bookstores, mass retailers, and other channels. The company licenses its Champion name for footwear and sports accessories. Hanesbrands Inc. provides its products primarily under the Hanes, Champion, Maidenform, Bali, JMS/Just My Size, Polo Ralph Lauren, Playtex, DKNY, Donna Karan, Alternative, Gear for Sports, Hanes Beefy-T, Bonds, DIM, Sheridan, Bras N Things, Nur Die/Nur Der, Lovable, Wonderbra, Berlei, Abanderado, Shock Absorber, Zorba, Explorer, Sol y Oro, and Bellinda brand names. The company markets its products through retailers, wholesalers, and third party embellishers, as well as directly to consumers through Internet. As of December 29, 2018, it operated 243 retail and direct outlet stores in the United States and the Commonwealth of Puerto Rico, as well as 690 retail and outlet stores internationally. The company also sells its products in Europe, Australia, Asia, Latin America, Canada, the Middle East, Africa, Mexico, and Brazil. Hanesbrands Inc. was founded in 1901 and is headquartered in Winston-Salem, North Carolina.

Volume

Today’s last reported volume for Hanesbrands is 3376950, 20.64% below its average volume of 4255300.

Hanesbrands’s last close was $17.16, 24.8% below its 52-week high of $22.82.

Hanesbrands’s Sales

Hanesbrands’s sales growth is a negative 2.5% for the ongoing quarter and 4.9% for the next. The company’s growth estimates for the present quarter and the next is 15.8% and 2.6%, respectively.

Hanesbrands’s Revenue

Year-on-year quarterly revenue growth grew by 5.8%, now sitting on 7.28B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Hanesbrands’s stock is considered to be overbought (>=80).

Hanesbrands’s Stock Yearly Top and Bottom Value

Hanesbrands’s stock is valued at $16.41 at 19:15 EST, way under its 52-week high of $22.82 and way higher than its 52-week low of $13.66.

Hanesbrands’s Moving Average

Hanesbrands’s value is under its 50-day moving average of $17.47 and way under its 200-day moving average of $18.86.

More news about Hanesbrands.

8. Regency Centers Corporation (REG) – Dividend Yield: 3.51%

Regency Centers is the preeminent national owner, operator, and developer of shopping centers located in affluent and densely populated trade areas. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member.

Volume

Today’s last reported volume for Regency Centers Corporation is 718244, 17.73% below its average volume of 873011.

Regency Centers Corporation’s last close was $73.80, 5.47% under its 52-week high of $78.07.

Regency Centers Corporation’s Sales

Regency Centers Corporation’s sales growth is 12.8% for the present quarter and 13.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 108.7% and 8.5%, respectively.

Regency Centers Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 28.1%, now sitting on 1.16B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Regency Centers Corporation’s stock is considered to be overbought (>=80).

Regency Centers Corporation’s Stock Yearly Top and Bottom Value

Regency Centers Corporation’s stock is valued at $71.26 at 19:15 EST, below its 52-week high of $78.07 and way higher than its 52-week low of $43.49.

Regency Centers Corporation’s Moving Average

Regency Centers Corporation’s worth is higher than its 50-day moving average of $71.15 and above its 200-day moving average of $64.79.

More news about Regency Centers Corporation.

9. Johnson & Johnson (JNJ) – Dividend Yield: 2.56%

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.

Volume

Today’s last reported volume for Johnson & Johnson is 14349800, 112.86% above its average volume of 6741570.

Johnson & Johnson’s last close was $159.75, 11.21% below its 52-week high of $179.92.

The company’s growth estimates for the current quarter and the next is 7.3% and 19.9%, respectively.

Johnson & Johnson’s Revenue

Year-on-year quarterly revenue growth grew by 27.1%, now sitting on 89.19B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Johnson & Johnson’s stock is considered to be overbought (>=80).

Johnson & Johnson’s Stock Yearly Top and Bottom Value

Johnson & Johnson’s stock is valued at $155.93 at 19:15 EST, way under its 52-week high of $179.92 and above its 52-week low of $142.86.

Johnson & Johnson’s Moving Average

Johnson & Johnson’s value is below its 50-day moving average of $162.51 and below its 200-day moving average of $167.48.

More news about Johnson & Johnson.

10. Diamond Hill Investment Group (DHIL) – Dividend Yield: 2.22%

Diamond Hill Investment Group, Inc., together with its subsidiaries, provides investment advisory and fund administration services in the United States. It sponsors, distributes, and offers investment advisory and related services to its clients. The company also provides fund administration services, including portfolio and regulatory compliance, treasury and financial oversight, and general business management and governance of the mutual fund complex, as well as oversight of back-office service providers, such as the custodian, fund accountant, and transfer agent. The company was founded in 1990 and is based in Columbus, Ohio.

Volume

Today’s last reported volume for Diamond Hill Investment Group is 15704, 152.35% above its average volume of 6223.

Diamond Hill Investment Group’s last close was $229.80, 0.03% below its 52-week high of $229.87.

Diamond Hill Investment Group’s Revenue

Year-on-year quarterly revenue growth grew by 59.5%, now sitting on 150.3M for the twelve trailing months.

Diamond Hill Investment Group’s Stock Yearly Top and Bottom Value

Diamond Hill Investment Group’s stock is valued at $220.35 at 19:15 EST, under its 52-week high of $229.87 and way higher than its 52-week low of $135.57.

Diamond Hill Investment Group’s Moving Average

Diamond Hill Investment Group’s worth is way above its 50-day moving average of $197.12 and way above its 200-day moving average of $175.84.

More news about Diamond Hill Investment Group.

LEAVE A REPLY

Please enter your comment!
Please enter your name here